Free Trial

Beneficient (BENF) Competitors

Beneficient logo
$0.30 0.00 (-0.33%)
As of 04:00 PM Eastern

BENF vs. LMFA, AIHS, SLNH, SHFS, CARV, NCPL, NRBO, PWM, MEGL, and SNTG

Should you be buying Beneficient stock or one of its competitors? The main competitors of Beneficient include LM Funding America (LMFA), Senmiao Technology (AIHS), Soluna (SLNH), SHF (SHFS), Carver Bancorp (CARV), Netcapital (NCPL), NeuroBo Pharmaceuticals (NRBO), Prestige Wealth (PWM), Magic Empire Global (MEGL), and Sentage (SNTG). These companies are all part of the "banking" industry.

Beneficient vs. Its Competitors

LM Funding America (NASDAQ:LMFA) and Beneficient (NASDAQ:BENF) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, profitability, earnings, media sentiment, valuation, analyst recommendations, risk, institutional ownership and community ranking.

LM Funding America received 138 more outperform votes than Beneficient when rated by MarketBeat users.

CompanyUnderperformOutperform
LM Funding AmericaOutperform Votes
138
56.33%
Underperform Votes
107
43.67%
BeneficientN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LM Funding America
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Beneficient
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

22.7% of LM Funding America shares are owned by institutional investors. Comparatively, 90.6% of Beneficient shares are owned by institutional investors. 36.1% of LM Funding America shares are owned by company insiders. Comparatively, 13.7% of Beneficient shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Beneficient has lower revenue, but higher earnings than LM Funding America.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LM Funding America$7.03M1.23-$15.94M-$6.76-0.25
Beneficient-$20.08M-0.13N/AN/AN/A

Beneficient has a net margin of 0.00% compared to LM Funding America's net margin of -96.23%. Beneficient's return on equity of 0.00% beat LM Funding America's return on equity.

Company Net Margins Return on Equity Return on Assets
LM Funding America-96.23% -35.84% -31.86%
Beneficient N/A N/A N/A

In the previous week, Beneficient had 1 more articles in the media than LM Funding America. MarketBeat recorded 5 mentions for Beneficient and 4 mentions for LM Funding America. LM Funding America's average media sentiment score of 0.32 beat Beneficient's score of -0.55 indicating that LM Funding America is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LM Funding America
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Beneficient
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Negative

LM Funding America has a beta of 1.45, meaning that its stock price is 45% more volatile than the S&P 500. Comparatively, Beneficient has a beta of -0.51, meaning that its stock price is 151% less volatile than the S&P 500.

Summary

LM Funding America beats Beneficient on 7 of the 12 factors compared between the two stocks.

Get Beneficient News Delivered to You Automatically

Sign up to receive the latest news and ratings for BENF and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BENF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BENF vs. The Competition

MetricBeneficientHolding Offices IndustryFinance SectorNASDAQ Exchange
Market Cap$2.63M$487.08M$11.73B$8.62B
Dividend YieldN/A7.67%5.66%4.17%
P/E RatioN/A2.5323.0519.96
Price / Sales-0.1383.4426.86157.63
Price / CashN/A69.0117.6034.64
Price / BookN/A6.432.894.69
Net IncomeN/A$35.76M$1.04B$248.14M
7 Day Performance-7.60%2.76%1.53%2.39%
1 Month Performance-1.94%4.14%1.45%6.05%
1 Year Performance-89.66%44.69%540.37%13.60%

Beneficient Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BENF
Beneficient
0.7032 of 5 stars
$0.30
-0.3%
N/A-91.8%$2.63M-$20.08M0.0080Analyst Revision
Gap Down
LMFA
LM Funding America
1.4219 of 5 stars
$2.05
+6.2%
N/A-64.8%$10.45M$7.03M-0.418High Trading Volume
AIHS
Senmiao Technology
0.3185 of 5 stars
$0.95
+4.3%
N/A+39.4%$9.98M$5.88M-2.97150News Coverage
Gap Down
SLNH
Soluna
1.7767 of 5 stars
$0.61
-1.4%
N/A-78.5%$8.47M$31.41M-0.0460News Coverage
Positive News
Gap Up
SHFS
SHF
0.7328 of 5 stars
$2.67
-4.0%
N/A-79.9%$7.43M$15.63M15.713Positive News
CARV
Carver Bancorp
1.1926 of 5 stars
$1.45
-4.3%
N/A-15.9%$7.38M$24.59M-0.75110Short Interest ↓
NCPL
Netcapital
1.063 of 5 stars
$2.72
+0.6%
N/A-65.7%$5.95M$812.61K-0.09N/ANews Coverage
Positive News
Gap Down
NRBO
NeuroBo Pharmaceuticals
N/A$0.65
-4.7%
N/A-80.7%$5.60MN/A0.0010News Coverage
Gap Down
High Trading Volume
PWM
Prestige Wealth
0.9642 of 5 stars
$0.37
-9.5%
N/A-48.4%$5.35M$639.91K0.004Short Interest ↓
MEGL
Magic Empire Global
1.6354 of 5 stars
$1.23
+1.7%
N/A-15.8%$5.00M$12.78M0.008News Coverage
Short Interest ↓
Gap Down
SNTG
Sentage
1.8182 of 5 stars
$1.70
+2.1%
N/A-14.5%$4.75M$107.51K0.0020Positive News

Related Companies and Tools


This page (NASDAQ:BENF) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners